0.36 USD
↘ 0.00 (0.17%)AT CLOSE (03:59 PM EDT)
Mustang Bio, Inc.
MBIONASDAQ • USD
0.37
↗ 0.01 (3.20%)
POST MARKET (AS OF 05:15 PM EDT)
Post Market
AS OF 05:15 PM EDT
0.37
↗ 0.01 (3.20%)
Market: OPEN
MBIO is currently priced at $0.37. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 27, 2026.
Open?$0.36
High?$0.39
Low?$0.35
Prev. Close?$0.36
Volume?25.6K
Avg. Volume?37.8K
VWAP?$0.36
Rel. Volume?0.68x
Bid / Ask
Bid?$0.31 × 100
Ask?$0.42 × 100
Spread?$0.11
Midpoint?$0.37
Valuation & Ratios
Market Cap?2.7M
Shares Out?6.7M
Float?6.2M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?0.36
EPS?-$0.40
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Themes
Employees
4
Market Cap
2.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2017-08-22
Address
95 SAWYER RD
WALTHAM, MA 02453
Phone: (781) 652-4500
WALTHAM, MA 02453
Phone: (781) 652-4500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?85
Piotroski F-Score?0/9Weak
Altman Z-Score?-35.88Distress
Confidence?43%Low
Short InterestLow
Short % of Float?0.95%Low
Short Interest?58.9K
Days to Cover?1.1
Free Float6.2M
Avg Daily Volume54.5K
Settlement Date2026-10-15
Financial Health
Current Ratio?1.97Adequate
Quick Ratio?1.97Adequate
Cash Ratio?1.91Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.36CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?3.5CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-40.2%WEAK▾
S&P3
ROA?-19.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-4511000
Enterprise Value?$-12422098
Fundamentals ratios updated end of day